478 related articles for article (PubMed ID: 32619884)
1. Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
Houot R; Levy R; Cartron G; Armand P
Eur J Cancer; 2020 Sep; 136():4-6. PubMed ID: 32619884
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 will change MS care forever - No.
Preziosa P; Rocca MA; Filippi M
Mult Scler; 2020 Sep; 26(10):1149-1151. PubMed ID: 32567471
[No Abstract] [Full Text] [Related]
3. Audio Interview: Covid-19 Vaccine Development.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Jul; 383(3):e40. PubMed ID: 32668131
[No Abstract] [Full Text] [Related]
4. COVID-19 disrupts vaccine delivery.
Nelson R
Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
[No Abstract] [Full Text] [Related]
5. COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.
Baker D; Roberts CAK; Pryce G; Kang AS; Marta M; Reyes S; Schmierer K; Giovannoni G; Amor S
Clin Exp Immunol; 2020 Nov; 202(2):149-161. PubMed ID: 32671831
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccine development pipeline gears up.
Mullard A
Lancet; 2020 Jun; 395(10239):1751-1752. PubMed ID: 32505245
[No Abstract] [Full Text] [Related]
7. Possible treatment of Covid-19 with a therapeutic vaccine.
Myint A; Jones T
Vet Rec; 2020 Apr; 186(13):419. PubMed ID: 32245869
[No Abstract] [Full Text] [Related]
8. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.
Abu-Raya B; Gantt S; Sadarangani M
CMAJ; 2020 Aug; 192(34):E982-E985. PubMed ID: 32646869
[No Abstract] [Full Text] [Related]
9. COVID-19 vaccines: no time for complacency.
The Lancet
Lancet; 2020 Nov; 396(10263):1607. PubMed ID: 33220729
[No Abstract] [Full Text] [Related]
10. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
Plotkin SA
J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616
[TBL] [Abstract][Full Text] [Related]
11. Development of vaccines for SARS-CoV-2.
Ng WH; Liu X; Mahalingam S
F1000Res; 2020; 9():. PubMed ID: 32850116
[TBL] [Abstract][Full Text] [Related]
12. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
13. In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction.
Silva-Arrieta S; Goulder PJR; Brander C
PLoS Pathog; 2020 Jun; 16(6):e1008607. PubMed ID: 32497149
[No Abstract] [Full Text] [Related]
14. Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot.
Rubin EJ; Baden LR; Piot P; Morrissey S
N Engl J Med; 2020 Jul; 383(5):e57. PubMed ID: 32726549
[No Abstract] [Full Text] [Related]
15. DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
Yu J; Tostanoski LH; Peter L; Mercado NB; McMahan K; Mahrokhian SH; Nkolola JP; Liu J; Li Z; Chandrashekar A; Martinez DR; Loos C; Atyeo C; Fischinger S; Burke JS; Slein MD; Chen Y; Zuiani A; Lelis FJN; Travers M; Habibi S; Pessaint L; Van Ry A; Blade K; Brown R; Cook A; Finneyfrock B; Dodson A; Teow E; Velasco J; Zahn R; Wegmann F; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kirilova M; Kordana N; Lin Z; Maxfield LF; Nampanya F; Nityanandam R; Ventura JD; Wan H; Cai Y; Chen B; Schmidt AG; Wesemann DR; Baric RS; Alter G; Andersen H; Lewis MG; Barouch DH
Science; 2020 Aug; 369(6505):806-811. PubMed ID: 32434945
[TBL] [Abstract][Full Text] [Related]
16. A vaccine is not too far for COVID-19.
Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
[No Abstract] [Full Text] [Related]
17. Coronavirus Vaccine: Light at the End of the Tunnel.
Ella KM; Mohan VK
Indian Pediatr; 2020 May; 57(5):407-410. PubMed ID: 32291382
[TBL] [Abstract][Full Text] [Related]
18. Status of COVID-19 vaccine development.
Taxt AM; Grødeland G; Lind A; Müller F
Tidsskr Nor Laegeforen; 2020 Sep; 140(13):. PubMed ID: 32998488
[TBL] [Abstract][Full Text] [Related]
19. A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.
Tai W; Zhang X; Drelich A; Shi J; Hsu JC; Luchsinger L; Hillyer CD; Tseng CK; Jiang S; Du L
Cell Res; 2020 Oct; 30(10):932-935. PubMed ID: 32759966
[No Abstract] [Full Text] [Related]
20. Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.
Bull World Health Organ; 2020 Sep; 98(9):588-589. PubMed ID: 33012858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
